NANOGEN ISSUED PATENT FOR PCR MONITORING METHOD

Nanogen, a developer of advanced diagnostic products, announced it was issued Patent No. 6,911,310, "Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system" by the U.S. Patent and Trademark Office. The '310 patent relates to a method of monitoring polymerase chain reaction (PCR) amplification of nucleic acid (DNA or RNA) using fluorescent resonant energy transfer, which is an essential part of molecular diagnostics.

MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqSYOWbWbmtG4CdCWmt)